About Phoenix Longevity Research

"Like the phoenix reborn from flame, our mission is to reignite vitality, restore beauty, and renew what time has diminished."

Our Mission

Phoenix Longevity Research & Consulting was founded on a simple but radical premise: the human lifespan limit may be far higher than we've been told — and the quality of those additional years can be extraordinary.

Research published in npj Aging estimates the human lifespan limit at 146 to 194 years. That validates our 150-year goal as not just aspirational, but scientifically grounded. The question isn't whether we can live longer — it's whether we can live better, longer.

What We Do

We research, curate, and consult on the most advanced longevity interventions available today — from peptide therapy and regenerative medicine to mitochondrial optimization, cognitive enhancement, and geroprotective supplements. Every protocol we recommend is backed by peer-reviewed research and real-world application.

Our flagship framework is the 150-Year Blueprint — a comprehensive protocol targeting all major hallmarks of aging simultaneously. Rather than addressing symptoms one at a time, the Blueprint takes a systems-level approach to extending both lifespan and healthspan.

Our Approach

We believe in three pillars:

  • RESEARCH — We stay at the cutting edge of longevity science, monitoring clinical trials, FDA regulatory developments, and breakthrough research from institutions worldwide.
  • RESTORE — We focus on evidence-based protocols that target the root causes of aging — mitochondrial decline, telomere shortening, immune senescence, and more.
  • RENEW — We believe in extending not just lifespan, but healthspan — the years lived in vitality, strength, and clarity.

The Science

The field of longevity research has accelerated dramatically. Recent breakthroughs include:

  • FDA advisory panel voting to ease restrictions on key peptides including BPC-157, KPV, MOTS-c, TB-500, Epithalon, and Semax
  • Semaglutide demonstrating the first clinical evidence of slowing biological aging markers
  • Retatrutide Phase 3 trials expanding with unprecedented metabolic results
  • Phosphatidylcholine research showing reversal of mitochondrial aging
  • Naked mole rat gene transfer extending mouse lifespan at the University of Rochester
  • NMN and stem cell synergy demonstrating rejuvenation in aged mice

We monitor these developments daily and translate them into practical, actionable protocols.

Stay Connected

Follow us on Facebook for daily longevity insights, breaking research updates, and practical tips you can apply today. Or reach out directly at joe@phxlr.com to learn more.